Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

181
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
181
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

245
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
245
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

43
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
43

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Mucosal and Systemic Immunity in an Observational Cohort of South African Children Hospitalised with Acute Respiratory Tract Infections.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Routine immunization uptake and timeliness in young children exposed to multidrug-resistant tuberculosis: A secondary analysis of the Tuberculosis Child Multidrug-Resistant Preventive Therapy multi-site randomised controlled trial.

BMC global and public health·2026
Same author

Acetylator status-guided rapid reintroduction of isoniazid in tuberculosis patients with drug-induced hepatotoxicity.

Journal of clinical tuberculosis and other mycobacterial diseases·2026
Same author

CMV viraemia is associated with mortality among children with HIV starting antiretroviral therapy in sub-Saharan Africa.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

Association between maternal organophosphate esters metabolite levels during pregnancy and internalizing and externalizing behaviors in children at 2-5 years.

Environmental epidemiology (Philadelphia, Pa.)·2026
Same author

Developing a multi-modal neuroimaging-based BrainAge model across childhood.

bioRxiv : the preprint server for biology·2026
Same journal

Multilevel onsite training and mentorship model to accelerate early childhood cancer diagnosis in Northwest Ethiopia: A quasi-experimental mixed method study.

PLoS medicine·2026
Same journal

The well-worn path from armed conflict to measles resurgence.

PLoS medicine·2026
Same journal

Association of armed conflict and global measles cases: A structural equation modeling analysis of 193 countries from 2000 to 2023.

PLoS medicine·2026
Same journal

Cardiovascular outcomes and safety associated with statin therapy for primary prevention in older adults with type 2 diabetes: A target trial emulation study.

PLoS medicine·2026
Same journal

Multi-omics biomarkers of endothelial dysregulation preceding chronic lung allograft dysfunction: A prospective cohort study.

PLoS medicine·2026
Same journal

Comparisons of core component delivery in cardiac rehabilitation programs by country income classification and decade based on the 2025 Global Audit Update: A survey study.

PLoS medicine·2026
See all related articles

Related Experiment Video

Updated: Jul 10, 2025

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

7.8K

Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.

Lufina Tsirizani Galileya1,2, Roeland E Wasmann1, Chishala Chabala1,3,4

  • 1Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

Plos Medicine
|November 21, 2023
PubMed
Summary
This summary is machine-generated.

Pediatric tuberculosis drug dosing needs optimization. Increasing rifampicin doses for children over 3 months can improve exposure and therapy, while HIV drug interactions require further study.

More Related Videos

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

Related Experiment Videos

Last Updated: Jul 10, 2025

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples
08:54

Validated LC-MS/MS Panel for Quantifying 11 Drug-Resistant TB Medications in Small Hair Samples

Published on: May 19, 2020

7.8K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.1K
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

7.9K

Area of Science:

  • Pharmacokinetics and pharmacodynamics
  • Pediatric infectious diseases
  • Tuberculosis treatment

Background:

  • Current World Health Organization (WHO) pediatric tuberculosis dosing guidelines result in suboptimal drug exposures.
  • Pediatric pharmacokinetic studies are often small, leading to variability and uncertainty in results.
  • Pooling data from large pharmacokinetic studies is essential for optimizing pediatric tuberculosis dosing.

Purpose of the Study:

  • To identify key covariates influencing drug exposure in children undergoing tuberculosis treatment.
  • To optimize tuberculosis dosing regimens for pediatric populations.
  • To characterize the pharmacokinetics of rifampicin, isoniazid, and pyrazinamide in children.

Main Methods:

  • Utilized nonlinear mixed-effects modeling to analyze pharmacokinetic data from 387 children across four countries.
  • Investigated the impact of human immunodeficiency virus (HIV), antiretroviral therapy (ART), drug formulation, age, and body size on drug pharmacokinetics.
  • Employed allometry to scale clearance and volume of distribution for rifampicin, isoniazid, and pyrazinamide.

Main Results:

  • Age significantly affected the bioavailability and clearance of rifampicin and isoniazid, with children reaching adult levels after 2 years and full clearance maturation around 3 years.
  • HIV infection itself did not alter pharmacokinetics, but antiretroviral therapy (ART) showed significant interactions: lopinavir/ritonavir decreased rifampicin clearance and increased pyrazinamide clearance, while efavirenz and lopinavir/ritonavir reduced isoniazid bioavailability.
  • Simulations indicated that current WHO-recommended doses lead to lower rifampicin exposures in children over 3 months, suggesting a need for dose adjustment.

Conclusions:

  • Children over 3 months exhibit lower rifampicin exposures than adults, necessitating dose increases of 75-150 mg to improve therapy.
  • Altered drug exposures in children with HIV are likely due to concomitant ART, not HIV infection itself.
  • Further evaluation of drug-drug interactions between tuberculosis medications and ART (lopinavir/ritonavir, efavirenz) is crucial for future dosing guidance.